LYTIR

Company · CTTH

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTH is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 8, 2026: insiders bought on 16 occasions ($5K); 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $5K in total; Insider sales: $0 in total.Aug: Insider purchases $2KSep: Insider purchases $2KOct: Insider purchases $653Nov: Insider purchases $450DecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $5KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. CTT PHARMACEUTICAL HOLDINGS, INC., CEO bought on 16 days latest Nov 4, 2026 bought $5K
Every trade (16)
  1. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Nov 4, 2026 9,000 shares filing $450
  2. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Oct 26, 2026 5,880 shares filing $335
  3. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Oct 15, 2026 2,000 shares filing $114
  4. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Oct 6, 2026 3,700 shares filing $204
  5. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Sep 28, 2026 3,400 shares filing $187
  6. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Sep 22, 2026 10,100 shares filing $454
  7. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Sep 16, 2026 10,900 shares filing $523
  8. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Sep 10, 2026 3,500 shares filing $175
  9. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Sep 4, 2026 9,800 shares filing $479
  10. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Sep 2, 2026 3,000 shares filing $147
  11. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Aug 31, 2026 3,500 shares filing $172
  12. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Aug 24, 2026 2,100 shares filing $116
  13. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Aug 20, 2026 11,500 shares filing $518
  14. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Aug 19, 2026 10,000 shares filing $590
  15. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Aug 14, 2026 1,800 shares filing $112
  16. BUYCTT PHARMACEUTICAL HOLDINGS, INC., CEO bought Aug 7, 2026 7,700 shares filing $500

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Oct 30, 2026
  2. Change in certifying accountant filing Oct 9, 2026
  3. Change in certifying accountant filing Oct 7, 2026
  4. Entry into a material definitive agreement; Other events filing Sep 23, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.